XML 38 R17.htm IDEA: XBRL DOCUMENT
v3.21.2

SHARE CAPITAL, EARNINGS PER SHARE AND DIVIDENDS | 12 Months Ended
--- | ---
Mar. 31, 2021
Share Capital, Reserves And Other Equity Interest [Abstract] |
SHARE CAPITAL, EARNINGS PER SHARE AND DIVIDENDS | SHARE CAPITAL, EARNINGS PER SHARE AND DIVIDENDS Share capital Authorized and issued shares The Company is authorized to issue an unlimited number of common shares without par value and an unlimited number of preferred shares without par value, issuable in series. The preferred shares may be issued with rights and conditions to be determined by the Board of Directors, prior to their issue. To date, the Company has not issued any preferred shares. As at March 31, 2021, the number of common shares issued and fully paid was 293,355,463 (2020 – 265,619,627). Issuance of common shares On November 30, 2020, the Company completed a public equity offering and a concurrent private placement of 16,594,126 common shares at a price of $29.85 per share for aggregate gross proceeds of $495.3 million. On March 12, 2021, the Company completed a marketed public equity offering of 10,454,545 common shares at a price of $34.29 (US$27.50) per share for gross proceeds of $358.5 million. Total issuance-related costs of the equity offerings amounted to $42.3 million, less income tax recovery of $11.2 million. Repurchase and cancellation of common shares On February 7, 2020, the Company announced the renewal of the normal course issuer bid (NCIB) to purchase up to 5,321,474 of its common shares. The NCIB began on February 25, 2020 and ended on February 24, 2021. Purchases were made on the open market plus brokerage fees through the facilities of the TSX and/or alternative trading systems at the prevailing market price at the time of the transaction, in accordance with the TSX’s applicable policies. All common shares purchased pursuant to the NCIB were cancelled. On April 6, 2020, the Company announced that it had temporarily suspended its NCIB in response to the COVID-19 pandemic (Note 3). The NCIB has since expired and has not been renewed. During the year ended March 31, 2021, no common shares were repurchased and cancelled under the NCIB (2020 ‑ 1,493,331 common shares at a weighted average price of $33.22 per share for a total consideration of $49.6 million). Earnings per share computation The denominators for the basic and diluted earnings per share computations are as follows:
|  | 2021 |  | 2020
Weighted average number of common shares outstanding |  | 272,009,538 |  |  | 265,951,131 |
Effect of dilutive stock options |  | — |  |  | 1,644,353 |
Weighted average number of common shares outstanding for diluted earnings per share calculation |  | 272,009,538 |  |  | 267,595,484 |
As at March 31, 2021, stock options to acquire 7,476,902 common shares (2020 – 1,293,200) have been excluded from the above calculation since their inclusion would have had an anti-dilutive effect. Dividends On April 6, 2020, the Company announced that it had temporarily suspended its common share dividends in response to the COVID-19 pandemic (Note 3). During the year ended March 31, 2021, no dividends were declared (2020 – $114.3 million or $0.43 per share).

X
- Definition Share Capital, Reserves And Other Equity Interest + References No definition available. + Details
Name: | cae_ShareCapitalReservesAndOtherEquityInterestAbstract
Namespace Prefix: | cae_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for share capital, reserves and other equity interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 79 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_79&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration